AU4937699A - Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing - Google Patents
Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healingInfo
- Publication number
- AU4937699A AU4937699A AU49376/99A AU4937699A AU4937699A AU 4937699 A AU4937699 A AU 4937699A AU 49376/99 A AU49376/99 A AU 49376/99A AU 4937699 A AU4937699 A AU 4937699A AU 4937699 A AU4937699 A AU 4937699A
- Authority
- AU
- Australia
- Prior art keywords
- andwound
- healing
- salts
- treatment
- succinic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/RU1999/000100 WO2000059499A1 (en) | 1999-04-05 | 1999-04-05 | Use of succinic acid or salts thereof for the treatment of diabetes mellitus and wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4937699A true AU4937699A (en) | 2000-10-23 |
Family
ID=20130334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU49376/99A Abandoned AU4937699A (en) | 1999-04-05 | 1999-04-05 | Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1165063A1 (en) |
AU (1) | AU4937699A (en) |
CA (1) | CA2362116A1 (en) |
WO (1) | WO2000059499A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020089444A (en) * | 2000-04-10 | 2002-11-29 | 베르텔레츠키 파벨 바실리에비치 | Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes |
US6797693B2 (en) | 2001-06-07 | 2004-09-28 | Wyeth | Methods using PTPase inhibitors and insulin |
AU2002344698B2 (en) * | 2001-07-10 | 2006-07-27 | Penam Investments Pty Ltd | A method of treatment and/or prophylaxis of ulcers |
AUPR626001A0 (en) * | 2001-07-10 | 2001-08-02 | Mcgregor, Neil | A method of treatment and/or prophylaxis |
WO2003055476A1 (en) * | 2001-12-25 | 2003-07-10 | Pomytkin Igor A | Use of succinic acid and salts thereof for inhibiting platelet aggregation |
AU2003236156A1 (en) * | 2003-04-24 | 2005-01-04 | Shin-Jen Shiao | Pharmaceutical compositions used for immune disease treatment and improvement |
JP2008500954A (en) * | 2003-10-27 | 2008-01-17 | メドベット・サイエンス・プロプライエタリー・リミテッド | Binding motifs and methods of modulating cell function |
JP5110898B2 (en) * | 2007-02-16 | 2012-12-26 | キヤノン株式会社 | Discharge liquid and discharge method |
EP3810121A1 (en) | 2018-06-22 | 2021-04-28 | Enzene Biosciences Ltd. | Succinic acid and derivatives for the treatment of haemotological disorders |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56125312A (en) * | 1980-03-09 | 1981-10-01 | Lion Corp | Remedy for damage |
JPS61171417A (en) * | 1985-01-23 | 1986-08-02 | Wakunaga Seiyaku Kk | Antidiabetic |
JP2844103B2 (en) * | 1990-02-09 | 1999-01-06 | 株式会社コーセー | External preparation for skin |
JP3581157B2 (en) * | 1992-08-19 | 2004-10-27 | 株式会社ミツカングループ本社 | Foods for people with low glucose tolerance |
JP3854326B2 (en) * | 1995-10-27 | 2006-12-06 | 株式会社ノエビア | Collagenase inhibitor |
ES2167751T5 (en) * | 1996-06-20 | 2012-03-30 | Novo Nordisk A/S | Insulin preparations containing a halide |
-
1999
- 1999-04-05 WO PCT/RU1999/000100 patent/WO2000059499A1/en not_active Application Discontinuation
- 1999-04-05 EP EP99933303A patent/EP1165063A1/en not_active Withdrawn
- 1999-04-05 CA CA002362116A patent/CA2362116A1/en not_active Abandoned
- 1999-04-05 AU AU49376/99A patent/AU4937699A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000059499A1 (en) | 2000-10-12 |
EP1165063A1 (en) | 2002-01-02 |
CA2362116A1 (en) | 2000-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL147822A0 (en) | Benzoic acid derivatives for the treatment of diabetes mellitus | |
AU2001601A (en) | Implantable substrates for healing connective tissue | |
AU2002218742A1 (en) | Application of photochemotherapy for the treatment of cardiac arrhythmias | |
AUPP609198A0 (en) | Use of non-peptidyl compounds for the treatment of insulin related ailments | |
AU4612300A (en) | Preventive or therapeutic drugs for diabetes | |
NO20006630L (en) | Pharmaceutical composition for the treatment of diabetes | |
AU2000276362A1 (en) | Composition for the treatment of diabetes | |
NO20022087D0 (en) | Procedure for the treatment of diabetes | |
AU2001292480A1 (en) | Novel pyridazine compounds for the treatment of diabetes | |
AU7870900A (en) | Treatment of scar tissue using lipoic acid | |
AU2003217275A1 (en) | Azabicyclic compounds for the treatment of disease | |
AU2003279442A1 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
AU2003295890A1 (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
AU4937699A (en) | Use of succinic acid or salts thereof for the treatment of diabetes mellitus andwound healing | |
AU2670600A (en) | Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence | |
AU2021601A (en) | Composition for the treatment of dandruff | |
AUPQ232599A0 (en) | Drug for treating fractures | |
AU1878201A (en) | Composition for the treatment of damaged tissue | |
AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
AU1022501A (en) | Use of compositions for the caring treatment of the skin | |
EP1177789A3 (en) | Use of phytanic acid for the treatment of diabetes | |
HUP0001841A2 (en) | Use of tranexamic acid for the preparation of a human fibrinogen composition | |
AU2683500A (en) | Compositions for the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |